By Yolanda Clarke, Colleen Mitchell
Apr 19, 2024
In an exciting week for the nascent Kentucky medical cannabis program, interested stakeholders were provided abundant new information to inform their business goals. Read this article for details on the new bill and regulations, and key licensing details—including medical cannabis business license caps.
By Colleen Mitchell
Feb 14, 2024
Missouri's cannabis market is expanding rapidly, offering a new opportunity for microbusinesses. The state plans to issue 48 microbusiness licenses in summer 2024, allowing smaller players to enter the cultivation, processing, and dispensary sectors. However, applications are competitive and require careful preparation, including team building, business formation, and real estate acquisition. This Insights post provides key details about the licensing process and eligibility criteria.
Nov 16, 2023
Watch this Vicente LLP live session replay regarding Mississippi's medical cannabis market. Panelists will discuss the latest happenings in Mississippi’s cannabis market, business licensing application requirements, operational compliance within a cannabis business, and the future of the state’s growing industry.
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
By Jason Adelstone
Nov 6, 2023
While the cannabis industry in the United States awaits a marijuana scheduling decision from the DEA, many countries around the world continue to move forward with liberalizing their cannabis policies as a superior method of promoting the health and welfare of their citizens. In this blog post, we’ll take a closer look at five countries poised to make waves in the cannabis landscape in 2024, including Germany, Thailand, Colombia, the Czech Republic, and Switzerland.
Oct 26, 2023
This recorded session features members of Vicente LLP’s Federal and International Law and Policy practice group and London cannabis attorney Robert Jappie of Fieldfisher sharing insights into what’s happening with cannabis and hemp-derived cannabinoids across the pond and opportunities for US operators and investors.
By Colleen Mitchell, Andrew Livingston
Sep 20, 2023
It has been over a year since Mississippi began accepting applications for medical cannabis business licenses and the market has steadily grown. Now, with the residency requirement gone and the passing of a new bill that made some positive changes to the program, it is an excellent time to enter this budding market. Read this article for market updates, including the number of patients, dispensaries, cultivators and processors, in addition to new opportunities created by House Bill 1158.
By Colleen Mitchell
Jul 31, 2023
Interested in applying for a Minnesota cannabis license? Now is the time to get involved in the initial rulemaking process, identify where you’d like to operate, and begin engaging with leaders and business owners in those communities.
By Colleen Mitchell, Yolanda Clarke
Oct 10, 2022
Prop 122 would create a regulated system for adults aged 21 and older to access natural psychedelic medicine, such as psilocybin, in a supervised setting to treat various mental health conditions. It would also allow for the cultivation, possession, personal use, and gifting of psychedelic medicine for adults aged 21 and older. Read this for an overview of the proposition’s key components.
By Colleen Mitchell, Jerrico Perez, Sally Kent Peebles
Jul 15, 2021
The Florida Department of Health (DOH) recently announced it is kicking off rulemaking for two separate competitive medical marijuana treatment center (MMTC) license application processes.
By Colleen Mitchell, Tucker Wentz
Jun 9, 2021
Montana lawmakers recently approved HB 701, which outlines key aspects of the framework that will govern the Treasure State’s new cannabis program.
By Charles Alovisetti
Jan 25, 2021
Like anything in the cannabis industry, getting a debt deal done requires navigating unique regulatory challenges. Here are seven regulatory considerations that cannabis borrowers and lenders should keep in mind when pursuing a debt transaction.
By Charles Alovisetti, Elliot Choi, Sahar Ayinehsazian
Sep 18, 2020
Raising private capital continues to be a challenge for the nascent cannabis industry, but there are proactive steps companies can take to maximize the chance of a successful raise.
